Avapritinib for the treatment of KIT mutation–negative systemic mastocytosis
Sign Up to like & getrecommendations! Published in 2022 at "Baylor University Medical Center Proceedings"
DOI: 10.1080/08998280.2022.2123661
Abstract: Abstract Systemic mastocytosis results from the spread of abnormal mast cells in different parts of the body, with variable clinical presentation. It is difficult to diagnose and to determine the appropriate therapy regimen. We present… read more here.
Keywords: mastocytosis; mutation negative; systemic mastocytosis; kit mutation ... See more keywords